Status:
COMPLETED
Immunemodulation in Patients With Minor Head Injury
Lead Sponsor:
Medical University of Vienna
Conditions:
Head Trauma
Eligibility:
All Genders
1+ years
Brief Summary
The purpose of this study is to try to prove the worth of the two (2) Serum Proteins S-100 Beta and NSE in combination with a diagnostic algorithm to help to establish diagnosis in patients with minor...
Eligibility Criteria
Inclusion
- minor head injury
Exclusion
- severe head injury
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT00622778
Start Date
October 1 2007
End Date
July 1 2011
Last Update
April 11 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Vienna, Austria, 1090